Erin Weeda to Atrial Fibrillation
This is a "connection" page, showing publications Erin Weeda has written about Atrial Fibrillation.
Connection Strength
1.759
-
Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis. J Thromb Thrombolysis. 2020 Apr; 49(3):360-364.
Score: 0.555
-
Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis. Curr Med Res Opin. 2016 06; 32(6):1117-20.
Score: 0.419
-
Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs. Int J Cardiol. 2016 Jan 01; 202:427-9.
Score: 0.406
-
Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response. Am J Emerg Med. 2020 11; 38(11):2271-2276.
Score: 0.135
-
Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2018 10 01; 4(4):328-329.
Score: 0.125
-
Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125.
Score: 0.119